← Back to headlines
Vera Therapeutics Gains After FDA Approval for Kidney Disease Therapy
Vera Therapeutics saw its shares rise following the FDA's approval of its new therapy for kidney disease.
7 Jul, 16:55 — 7 Jul, 16:55
Sources
Showing 1 of 1 sources
